TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Colony stimulating factor 1 receptor (CSF-1R) is crucial for monocyte/macrophage regulation in cancer development.
• Transforming growth factor-β stimulated clone-22 (TSC-22) is implicated in tumorigenesis, inhibiting cancer cell proliferation and inducing apoptosis.
• CSF-1R is a potential therapeutic target for anti-cancer strategies.

Purpose of the Study:

• To investigate the interaction between TSC-22 and CSF-1R.
• To elucidate the role of this interaction in cervical cancer.
• To evaluate the therapeutic potential of targeting the TSC-22-CSF-1R axis in cervical cancer.

Main Methods:

• Identified CSF-1R as a novel interacting partner of TSC-22 using biochemical assays.
• Investigated the binding site of TSC-22 on CSF-1R (intracellular tyrosine kinase insert domain 539-749).
• Assessed the impact of TSC-22/CSF-1R interaction on AKT, ERK, and NF-κB signaling pathways.
• Evaluated the effect of TSC-22 overexpression and CSF-1R reduction on cervical cancer cells in vitro and in a xenograft mouse model.

Main Results:

• Discovered TSC-22 interacts with the intracellular domain of CSF-1R, inhibiting AKT and ERK signaling and suppressing NF-κB transcriptional activity.
• Demonstrated that TSC-22 overexpression reduces CSF-1R protein levels, disrupting the autocrine loop.
• Observed significant inhibition of tumor growth in a human cervical cancer xenograft model upon TSC-22 injection.
• Showed that reduced CSF-1R expression suppresses cervical cancer cell proliferation and motility while inducing apoptosis.

Conclusions:

• The interaction between TSC-22 and CSF-1R represents a novel mechanism in cervical cancer progression.
• Targeting the TSC-22-CSF-1R pathway holds promise as a new therapeutic strategy for cervical cancer.
• The TSC-22-CSF-1R association may serve as a valuable prognostic marker for cervical cancer.